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Highlights 
 Individuals with mental disorder demonstrate higher levels of affective lability and lower 
affect control than those without mental disorder. 
 Affective intensity may not be useful in demarcating abnormal affective experience. 
 Independent of diagnosis, affect lability, adversely impacts day-to-day functioning. 
 Affective instability could be a novel target for clinical intervention trans-diagnostically. 
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Abstract 
Background: Affective instability (AI) is transdiagnostic, and associated with suicidality and 
healthcare use. It has rarely been compared between diagnoses or to controls. We 
investigated: whether AI differs between clinical cases and controls and between diagnoses; 
how different AI components are correlated; and whether AI is associated with functioning in 
clinical cases. 
Methods: Cases (N=69) from psychiatric services had a diagnosis of borderline personality 
disorder, bipolar disorder, major depression or psychosis and were compared to primary care 
controls (N=25). Participants completed the affective lability scale (ALS), affective intensity 
measure (AIM), affective control scale (ACS), scored mood fluctuation rate and the WHO-
DAS. 
Results: There was a significant difference in affective lability between cases and controls 
and across diagnostic groups (p< 0.001). Compared to controls, cases showed lower affective 
control (p<0.05). There were no differences in affective intensity between cases and controls 
or between diagnostic groups, or in mood fluctuation rate between groups. ALS score 
(p<0.001), and total number of medications (p<0.046), were associated with functioning, 
independent of diagnosis. 
Limitations: The sample size was modest. Cases were not in an acute illness episode and this 
could bias estimates of group difference towards the null. 
Conclusion: Individuals with mental disorder demonstrate higher levels of affective lability 
and lower affect control than those without mental disorder. In contrast affective intensity 
may not be useful in demarcating abnormal affective experience. Independent of diagnosis, 
affective instability, as measured by affect lability, adversely impacts day-to-day functioning. 
It could be an important target for clinical intervention. 
Key Words: affective instability, functioning, mood instability, depression, bipolar disorder 
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1. Introduction 
Affective Instability (AI) is a transdiagnostic symptom (Broome et al., 2015b; Henry et al., 
2001b). It has been defined as rapid oscillations of intense affect, with difficulty regulating 
these or their behavioural consequences (Marwaha, 2013). Multiple strands of evidence have 
associated AI with suicidal thinking (Palmier-Claus et al., 2012; Yen et al., 2004), health 
service use (Marwaha et al., 2013c), new onset of depression (Marwaha et al., 2015), 
psychotic symptoms (Marwaha et al., 2013a), onset of bipolar disorder and increasing time to 
recovery (Howes et al., 2011; Stange et al., 2016). It is also independently linked to greater 
medication use and detention under mental health legislation (Patel et al., 2015). It is 
associated with childhood trauma experiences (including abuse) and it is suggested that it 
may partly explain the connection between these and psychiatric disorders (Aas et al., 2016; 
Marwaha et al., 2016; Moffa et al., 2017). The estimated prevalence of AI in the general 
population is 14%, with levels being higher in younger people and women (Marwaha et al., 
2013c; Patel et al., 2015). We (Broome et al., 2015a), and others (Harrison et al., 2017) have 
suggested that trans-diagnostic investigation of AI is compatible with the NIMH Research 
Domain Criteria project (Insel, 2014), a framework for understanding mental disorders by 
study of dysfunction in individual psychological and biological systems. 
 
Through systematically reviewing the literature we have previously identified AI as 
having three core affect components: intensity, lability, and ability to control the oscillations 
or their behavioural consequences  (Marwaha et al., 2014). The review also identified that 
comprehensive measurement of all three components is rarely undertaken. The current 
literature is limited in part by theoretical and methodological heterogeneity in how AI is 
understood and assessed. This means that studies of AI in different diagnostic groups cannot 
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be compared, and hence understanding whether AI is similar in different disorders and how it 
contributes to outcomes such as functioning are hard to ascertain. As such, there is a 
significant gap in understanding this clinical phenomenon. A second major shortcoming of 
the current literature is that nearly all studies to date, apart from a few notable exceptions 
(Ben-Zeev and Young, 2010; Ben-Zeev et al., 2009), have lacked comparisons with 
individuals without mental disorder. This means it is unclear how far AI represents 
psychopathology needing intervention or indeed whether it is a core aspect of abnormal 
mental states, or is a feature of normal mental life. 
 
To our knowledge, only three studies to date have compared AI in different diagnostic 
groups using the same assessment procedures but limiting assessment of AI to two if its 
domains. Henry et al. (2001a) examined AI using the Affect Lability Scale (ALS) and Affect 
Intensity Measure (AIM) in out-patients with Borderline Personality Disorder (BPD) (N=29), 
bipolar disorder: type II without BPD (N=14), BPD and bipolar disorder: type II (N=12), and 
no BPD or bipolar disorder but other personality disorders (N=93). Lability scores were 
significantly (p< 0.05) higher in BPD, whilst bipolar patients tended (p=0.06) to have higher 
lability scores than other personality disorders. No differences in affect intensity were 
observed.  
 
In a similar study those with bipolar disorder had significantly higher scores on the 
euthymia-elation subscale of the ALS as well as significantly higher scores on affect 
intensity, whereas those with BPD experienced more shifts between anxiety-depression, 
euthymia-anger and significantly fewer shifts between euthymia-elation and depression-
elation (Reich et al., 2012). Most recently Richard-Lepouriel et al (Richard-Lepouriel et al., 
2016) compared ALS and AIM scores in people with bipolar disorder, attention deficit 
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hyperactivity disorder (ADHD) and controls (dentistry students and doctors). Those with 
ADHD and bipolar disorder scored higher on ALS than controls, with AIM scores being 
highest for ADHD. Whilst affective lability appears to be higher in BPD, and people with 
bipolar disorder, results for affective intensity are discrepant between studies with some 
evidence that affective intensity may be higher in people with mental disorders than in 
controls. 
 
Given the paucity of previous research, we aimed to expand the diagnostic groups in 
which AI is examined (given the suggestion that AI is transdiagnostic), compare these 
“cases” with psychologically “healthy controls”, assess AI more comprehensively, and test 
whether AI is independently linked to functioning within a clinical population. 
 
2. Aims 
 
We aimed to answer the following research questions: 
 
1. Does affective instability differ between clinical cases and controls and between 
diagnostic groups? 
2. To what extent are measures of affective lability, intensity and ability to control affect 
correlated in a trans-diagnostic clinical sample? 
3. Is affective instability associated with functioning in a clinical population independent 
of diagnosis? 
3. Methods 
We undertook a case-control study among users of secondary care mental health services 
(cases) and primary care attenders without evidence of current mental disorder (controls). 
Ethical approval was obtained from the Coventry and Warwickshire Ethics Committee, UK. 
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Participant consent and data collection was completed by an experienced researcher with a 
psychology background. 
 
3.1 Participants 
 
Individuals with a range of diagnoses were recruited from secondary care mental 
health services within Coventry and Warwickshire, UK through convenience sampling. The 
aim was to include individuals who were representative of the ‘typical’ case mix of these 
services, so participants were recruited in out-patient departments, day hospitals, community 
mental health teams and a specialist personality disorder service. Inclusion criteria were: a] 
aged 18-65 years; b] capacity to give informed consent; c] the primary reason for attending 
the mental health service was for management of a clinical diagnosis of BPD, bipolar 
affective disorder, major depressive episode (moderate or severe depressive episode) or non-
affective psychosis as reported by a Consultant Psychiatrist. The researcher confirmed the 
diagnosis with the Psychiatrist using ICD-10 criteria. 
 
Exclusion criteria were: a] an acute illness episode (sufficient to require urgent or 
inpatient care) according to the patient’s Consultant Psychiatrist; b] unable or unwilling to 
complete the assessments (e.g. individuals with a clinically assessed learning disability, with 
insufficient command of the English language to understand and complete questionnaires); or 
c] individuals with a primary ICD-10 diagnosis of dependency to drugs or alcohol (to avoid 
confounding by drug or alcohol misuse). 
 
Control participants were recruited from primary care (general practitioner surgeries). 
Physicians asked patients if they were interested, a researcher in the waiting room then 
consented the patients and completed the battery of questionnaires.  Exclusion criteria for the 
control group were: a] presence of a current mental disorder (including common mental 
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disorders such as depression or anxiety disorders); b] dependency on substances or alcohol; 
c] previous diagnosis of BPD, bipolar disorder, or non-affective psychosis, according to their 
primary care records.   
 
3.2 Materials 
 
Details were collected on participants’ diagnosis (for cases) and confirmed by their 
Consultant Psychiatrist. Details on duration of illness (cases only) and current medications 
were identified by a researcher, from clinical records. Medications were grouped as anti-
psychotic, anti-depressant, anti-anxiety, mood stabiliser, anti-depressant/mood-stabiliser or 
‘other’ (medication not directly related to the patient’s psychiatric diagnosis). 
Sociodemographic information was collected on age (years), gender, marital status 
(married/cohabiting, single, separated/widowed), employment (employed, unemployed, 
other), ethnicity (White British, other), and highest education level (None/GCSE, A Level, 
Degree/higher degree) (see Table 1).  
 
3.3 Assessment scales 
 
Participants were asked to complete four questionnaires relating to affective / mood 
instability.  
1. The Affective Lability Scale - short form (ALS-18) (Harvey et al., 1989), is a 
reliable and valid measure comprising 18 items coded 0-3. Overall score is 
obtained by taking the mean of the scores for each item as indicated by the scale 
developers. Three subscales can be derived; ‘anxiety-depression’, ‘depression-
elation’, and ‘anger’.  
2. The Affective Intensity Measure-20 (AIM) (Larsen et al., 1986a) was used to 
measure affect intensity. The AIM contains 20 items coded 1 to 6. A person’s 
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overall score is obtained by taking the mean of the scores for each item. The AIM 
has good internal consistency, test-retest reliability and construct validity (Larsen 
et al., 1986b).  
3. The Affective Control Scale (ACS) (Williams et al., 1997) comprises 42 items, 
coded 1 to 7 (with some items requiring reverse scoring); it has good 
psychometric properties including construct validity. A higher ACS score 
indicates reduced ability to control affect. Four subscales can be derived; ‘anger’, 
‘positive affect’, ‘depressed mood’, and ‘anxiety’.  
4. Mood fluctuation rate: Because of the lack of a previously well validated scale for 
fluctuation rate (Marwaha, 2013) we used a new bespoke schedule for this study. 
Mood fluctuation rate was assessed using a question from the Structured Clinical 
Interview for DSM Disorders (SCID). It asks the respondent to state how often 
they experienced a sudden marked shift in mood. Study participants rated the 
number of significant mood fluctuations they experienced over a week. 
Respondents were asked to consider this for each one of the weeks in the last 
month prior to assessment, and possible responses were 0, 1-3, 4-7, or >7 mood 
changes over each week.  
 
Functioning was measured using the WHO Disability Assessment Schedule 2.0 – 12 
item version (WHODAS; (Üstün, 2010). This contains 12 items each coded 0 to 4. To obtain 
a person’s final score, the simple version entails summing the scores from each of the 12 
items, scores range from 0-48. For consistency in comparing with the other scores above, the 
mean rather than the sum was used in the current study.  
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3.4 Data analysis 
 
Descriptive statistics including means/medians with standard deviations/interquartile ranges, 
or frequencies with percentages where relevant, were used to investigate participant 
demographics and characteristics of AI in the different diagnostic groups and controls.  There 
are no clear rules about the acceptable fraction of missing data to justify imputation. As such, 
we decided on 10%, as a level that would allow imputation, thus enabling us to use as much 
of the data as possible, whilst also retaining reliability and accuracy (Steyerberg, 2008). As 
such scores were imputed if the patient had less than 10% missing items. This translates as: 
AIM: Up to 2 missing values, ALS-18: Up to 2 missing values, ACS: Up to 4 missing values, 
WHODAS: 1 missing value. 
 
Two sample t-tests were used to compare means between the cases and controls after 
verifying that relevant assumptions were valid. Proportions were compared using chi-squared 
tests. General linear models (GLMs) were used to compare the mean lability (ALS), intensity 
(AIM), and subjective ability to control affect (ACS) outputs across cases (different 
diagnostic groups) and the control group. Adjustment was made for age, sex and educational 
level if necessary. Model assumptions were checked and, in the case of an overall significant 
difference in mean score across the diagnosis groups, pairwise post-hoc comparisons of 
adjusted mean scores were performed with a Bonferroni correction. To investigate how far 
the different aspects of affective instability correlate with each other, the linear association 
between each pair of measurement scales for the full sample and for the cases only was 
assessed using Pearson’s product moment correlation. Association between each 
measurement scale and the mood fluctuation rate was assessed using Spearman’s rank 
correlation. 
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Multiple regression was used to examine the association between affective instability 
and general assessment of functioning as measured by the WHODAS (Üstün, 2010) in 
clinical cases, adjusting for diagnosis and other patient characteristics. A purposeful selection 
approach was used to fit the model. Manual backward elimination was first used to remove 
variables based on Wald statistics using p = 0.05 as the cut-point for removal. Removed 
variables were then re-entered into the model one-by-one to check their significance. 
Variables initially considered in the model included: (a) socio-demographics: age, sex, 
ethnicity, education level, marital status, (employment status was not considered in the model 
since the WHODAS incorporates this parameter in ratings), (b) illness characteristics: 
diagnosis, duration of illness, total number of medications, (c) AI measures: mood fluctuation 
rate and the mean scores for the ACS, ALS-18 and AIM. All analyses were conducted in 
IBM SPSS Statistics 24.  
 
4. Results 
 
4.1 Participant characteristics 
 
The initial dataset comprised 101 participants, but 9 individuals were excluded due to 
missing data (3 bipolar, 2 major depression, and 2 controls). Hence the final sample (N=94) 
comprised of 69 cases and 25 controls. 
      
Table 1 describes the socio-demographic characteristics of included participants by 
group (case versus control), and diagnostic subgroups (bipolar disorder (n=11), BPD (n=12), 
psychosis (n=21), and major depression (n=25)). There was a significant difference between 
cases and controls in mean age (p=0.001), employment status (p=0.001) and marital status 
(p<0.001). Age was controlled for during regression analysis as AI is influenced by this 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 12 
(Marwaha et al., 2013b). Duration of illness was recorded in the dataset for 67 out of the 69 
cases and was positively skewed with the sample having been ill for a median duration of 36 
months (interquartile range (IQR) 15-156 months). Across the diagnostic groups, participants 
with depression reported the longest duration of illness (median 120 months, IQR 12-258), 
followed by participants with BPD (median 36 months, IQR 24-120), psychosis (median 27 
months, IQR 20.5-111), and bipolar disorder (median 24 months, IQR 9-36), respectively. 
    
Table 1 about here 
 
The commonest class of medication prescribed was anti-depressants, and most patients 
reported being prescribed one (25%) or two (25%) medications. Seventeen percent of cases 
(N=12) were not taking any medication. We did not explore, type of medications and their 
impact on our results because of the lack of a robust typology of the effectiveness of 
medications indicated for affective instability (Lieb et al., 2010). 
 
4.2 Comparison of questionnaire scores between cases and controls 
Differences in the unadjusted mean scores between cases and the controls for all 
measures are presented in Table 2. Age and sex were found not to be significant across the 
sample in the general linear model (GLM) for the ACS, AIM, and WHODAS scores; whilst 
there was trend towards significance for the effect of age on ALS score (P = 0.068).  
 
Table 2 about here 
 
Affect lability (ALS): When adjusted for age, a statistically overall significant 
difference was observed in mean ALS-18 scores between cases and controls (F (4,88) = 
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7.195, p < 0.001). Post-hoc pairwise comparisons of mean scores revealed significantly lower 
mean ALS-18 scores for the control group compared to each diagnosis group but no 
significant differences between diagnoses.  
 
Affect intensity (AIM): There was little difference in the mean AIM scores between 
groups, with slightly higher mean scores found for controls compared to cases. These 
differences were not statistically significant (p = 0.867).  
 
Ability to control affect (ACS): An overall significant difference was found between 
mean ACS scores across the different diagnostic groups, including controls (F (4,89) = 
14.520, p < 0.001). Post-hoc pairwise comparisons of the mean scores revealed significantly 
higher mean ACS scores (meaning lower control) for each diagnostic group compared to 
controls (p < 0.05). A significant difference was also found between the mean scores in 
borderline personality disorder patients and patients with non-affective psychosis (p = 0.010). 
 
Mood fluctuations in the last week: Table 2 shows the number of participants (i.e. 
frequency with percentage) who reported each number of mood fluctuations over the past 
week prior to assessment. This revealed that cases tended to have more changes in their mood 
state than controls, although no overall differences were found in rate of mood fluctuation 
between groups (p=0.310). Those with major depression reported the greatest number of 
mood fluctuations in the last week, followed by non-affective psychosis, borderline 
personality disorder and then bipolar disorder.  
 
4.3 Correlations between different components of AI, mood fluctuation rate and functioning 
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Correlations are shown in table 3. Strong positive correlations were found between 
the ALS and the ACS in the full and cases only analysis. Weak to moderate correlations were 
found between the AIM and the ALS. When assessing the association between each 
measurement scale and mood fluctuation rate ‘last week’, moderate to strong positive 
correlations were found between mood fluctuation and ALS and ACS. There was a weak 
correlation between AIM and mood fluctuation rate. All correlations were weaker when 
focusing on the cases only. 
 
Table 3 about here 
 
4.4 AI and functioning 
 
 In the clinical sample, an overall significant difference was observed between mean 
WHODAS scores across the different diagnosis groups, F (4,89) = 11.454, p < 0.001 (p < 
0.05 for bipolar disorder). Post-hoc pairwise comparisons revealed significantly lower mean 
WHODAS scores for the control group compared to each diagnosis group, as might be 
expected, but differences between diagnostic groups were not significant. 
 
A multiple regression model investigating factors associated with the WHODAS 
score, demonstrated that both ALS-18 and ACS scores were significantly associated with 
current level of functioning. After correcting for multicollinearity, ALS-18 score was retained 
in the final model (beta=0.845, p<0.001), along with the total number of medications 
(beta=0.107, p<0.046). All other variables considered, including diagnosis, were not 
significantly associated with WHODAS score in the final model. 
 
5. Discussion 
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5.1 Main findings 
 
This is the first study, to our knowledge, that has comprehensively assessed the core 
components of affective instability in a trans-diagnostic clinical population and compared 
clinical cases with a control group without mental disorder. We found only affective lability 
and affective control is significantly different in people with a range of mental disorders in 
comparison to those without. No differences were observed between people with and without 
mental disorder in the intensity of affect experienced or the rate of mood fluctuation in the 
last week. Two of the three components of affective instability (lability and intensity) did not 
differ significantly between individuals with different psychiatric diagnoses, although ability 
to control affect was significantly different in individuals with BPD in comparison to non-
affective psychosis. Whilst the small numbers within each diagnostic group mean that 
interpretation can only be exploratory, contrary to expectation, we found that the greatest 
number of mood changes in a week was experienced by people with major depression, 
followed by non-affective psychosis, BPD and then bipolar disorder. 
 
 In terms of the affective instability construct, the strongest inter-correlation was found 
between lability and ability to control affect, with much weaker (modest) correlations 
between affective intensity and ability to control affect (or lability and control). Finally, only 
affective lability, but not affective intensity, ability to control affect or mood fluctuation rate 
was associated within functioning independent of diagnosis and other important confounders. 
 
 5.2 Limitations 
 
Our sample size was relatively modest (just under 100). This limited the statistical 
power of our analyses and increased the risk that our results might be due to type II error. 
This means that comparisons of affective instability between diagnostic groups in particular, 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 16 
should be considered entirely exploratory, and other interpretations tentative. Another caveat 
to comparisons between diagnoses is that we did not complete inter-rater reliability 
assessments. However, this is the largest study to date exploring our questions.  
 
Our observations related to affective instability are limited to the four mental 
disorders that we sampled. We cannot therefore generalize our findings to other disorders, 
where affective instability is known to be important such as OCD (Bowen et al., 2015) or 
ADHD (Asherson et al., 2007). Furthermore, we could not take into account the contribution 
made by mental or physical comorbidities in our sample. However, given our sample of cases 
were those in contact with secondary mental health services there are likely to be high levels 
of comorbidity. Therefore, it is possible that high levels of affective lability and problems 
with affective control are linked to comorbidity and this should be the focus of future studies. 
In our regression modelling we were not able to control for some factors known to impact 
functioning such as cognition, illness severity, premorbid functioning and depressive 
symptoms. 
 
The cases sampled were not in an acute illness episode and it is conceivable that this 
biased estimate of group difference towards the null, that is, there is no difference between 
the cases and controls on affective instability measures. Affect intensity (and possibly 
instability) might vary with illness acuity, which might explain why differences between 
cases and controls in the present study were smaller than those reported in an in-patient 
sample (Henry et al., 2008; Reich et al., 2012).  Whilst we did not assess illness severity, we 
adjusted for illness duration and number of medications, both of which might be expected to 
be associated with illness severity. More specifically, we also did not assess current mood 
state using standardised measures and therefore do not know how far the severity of current 
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mood (e.g depth of depression) could have impacted on our results. There is little current 
evidence on how far AI changes, as mood becomes lower or more elated to guide how this 
could have influenced out main findings. Indeed, in bipolar disorder, AI is found in both 
euthymic and periods of acute illness (Harvey, 2008). We explored whether AI is different 
between cases and controls. Future studies should also aim to explain the differences between 
affective instability in people with mental disorders and without. 
 
We used assessment measures which require recall of affective experiences. These 
may be prone to bias, particularly when compared to ecological momentary assessments 
(EMA) (Broome et al., 2015b). How accurately people with mental disorders recall their 
affective experiences might differ depending on diagnosis. The ratings themselves at an 
individual level may also be dependent on an initial calibration to understand what is meant 
by a “marked” shift in mood (Holmes et al., 2016). Therefore, paradoxically individuals with 
fewer mood fluctuations may better report retrospective fluctuations as they would have 
stood out in their experience, whilst those with more frequent fluctuations may only report 
“marked” ones, as small fluctuations were perhaps normalised by their experience. This is 
one potential explanation of why depressed patients reported more fluctuations than other 
groups, though this was not statistically significant. The question used to assess mood 
fluctuation didn’t specify type of affect and therefore could have excluded swings in anger 
and irritability, which have been shown to differentiate between diagnosis (Tsanas et al., 
2016). We also recognise that current mood state may have impacted on assessment.  
 
Whilst momentary assessment of psychopathology appears feasible using 
smartphones (Tsanas et al., 2016), it is as yet unclear whether retrospective affective 
assessments and EMA relate to the same underlying psychological or biological processes, 
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especially as the former will be subject to important cognitive processes (e.g contextual 
processing), which control how mood is experienced (Dubad et al., 2018). There is also the 
issue of how far individuals recognize and name affective states in the same way.  
 
5.3 Theoretical and clinical implications 
 
 
Our findings only partly validated our original definition of affective instability as a 
trans-diagnostic parameter incorporating affect lability, ability to control and intensity 
(Marwaha et al., 2014). Affect lability and the ability to control these were indeed found to 
occur at higher levels than in controls and at similar levels across the different diagnostic 
groups. Scores on both measures were also relatively strongly correlated with each other re-
enforcing the notion that they are facets of the same or similar underlying latent construct. 
Affective intensity was only relatively weakly associated with other affective instability 
measures. Replication in a much larger sample is required to understand how far this pattern 
holds true. In the current study affective intensity was no different between cases and controls 
or between the cases themselves consistent with previous literature (Henry et al., 2001b). 
Whilst caution is necessary in interpretation, this does suggest that intensity of affect may not 
be a feature that may help delineate the boundaries of “normal” or “abnormal” affective 
experience, or at least in the way that it was measured here. Again, a study with a larger 
sample size is required. 
 
Mood fluctuation rate (as measured by our bespoke instrument) showed some 
concurrent validity with two measures of affective instability, and surprisingly, fluctuation 
rate was no different between cases and controls. This may be a function of our sample size, 
but this finding should prompt larger studies, with more comprehensive fluctuation change 
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assessments to investigate this area. Crucially, these studies need to include people without 
mental disorders as controls. 
 
We used a comprehensive way to measure affective instability in people with 
different diagnoses and the current results as well as previous research provides some 
counterbalance to the notion that affective instability is specific to or more severe in people 
with bipolar disorder or borderline personality disorder. The challenge now is to understand 
whether more subtle differences exist that may be clinically useful, such as whether a 
particular valence change is more or less common in different disorders (Reich et al., 2012) 
or whether richer, digitally captured mood data is helpful in differentiating disorders. Current 
evidence indicates clinicians do not use diagnostic criteria effectively to distinguish disorders 
such as BPD and bipolar disorder in which affective instability symptoms are seen to overlap 
(Saunders et al., 2015). Further research into common and uncommon valence changes in the 
disorders, perhaps incorporating digital mood monitoring, may help to resolve this clinical 
difficulty. 
 
Finally, we demonstrate that affective instability independently adversely impacts 
functioning in people with mental disorders, and this is independent of diagnosis. The 
measure of functioning that we used suggests the impact could be on multiple domains 
including learning new tasks, joining in community activities, day to day work and 
maintaining friendships. We have previously found that interpersonal conflict is part of the 
pathway from affective instability and incident depression (Marwaha et al., 2015) and the 
current study is also consistent with other work highlighting the impact of affective instability 
on functioning in bipolar and transdiagnostically (Patel et al., 2015; Strejilevich et al., 2013). 
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We extend these previous findings by identifying that affective lability, as opposed to other 
aspects of AI such as ability to control affect or intensity, has the greatest impact.  
 
As such affective lability has the potential for being a therapeutic target that could 
improve functional outcomes in mental disorders. Pharmacological interventions that are 
widely used (e.g mood stabilising antipsychotics) and emotional regulation training (Berking 
et al., 2008) need more robust trial evidence, but could have a significant impact on distress 
and outcomes. 
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Table 1: Descriptive statistics by group; case versus control and diagnosis subgroups (n = 94) 
Characteristic 
Control 
(n = 25) 
Case 
(n = 69) 
Cases by diagnosis 
Total 
(n = 94) 
 
 
 Case versus control 
Bipolar 
(n = 11) 
Borderline 
(n = 12) 
Psychosis 
(n = 21) 
Depression 
(n = 25) 
 
P 
value 
Test 
Age (years); mean (SD) 
48.5 
(10.8) 
38.2 
(12.8) 
35.6 
(13.3) 
33.9 (11.0) 34.9 (9.8) 44.2 (14.1) 
41.0 
(13.1) 
0.001 t test 
Male; n (%) 9 (36.0%) 
36 
(52.2%) 
6 
(54.5%) 
2 (16.7%) 
12 
(57.1%) 
16 (64.0%) 
45 
(47.9%) 
0.165 Chi square test 
Employment; n (%):        
0.001 
Chi Square test 
(employed vs 
unemployed, n = 
90) 
 Employed 19 
(76.0%) 
26 
(37.7%) 
5 
(45.5%) 
4 (33.3%) 6 (28.6%) 11 (44.0%) 
45 
(47.9%) 
 Unemployed 5 (20.0%) 
40 
(58.0%) 
6 
(54.5%) 
8 (66.7%) 
14 
(66.7%) 
12 (48.0%) 
45 
(47.9%) 
 Other 1 (4.0%) 3 (4.3%) 0 (0.0%) 0 (0.0%) 1 (4.8%) 2 (8.0%) 4 (4.3%) 
Ethnicity; n (%)        
0.259 
Chi square test 
 White British 18 
(72.0%) 
57 
(82.6%) 
9 
(81.8%) 
10 (83.3%) 
14 
(66.7%) 
24 (96.0%) 
75 
(79.8%) 
 Other 7 (28.0%) 
12 
(17.4%) 
2 
(18.2%) 
2 (16.7%) 7 (33.3%) 1 (4.0%) 
19 
(20.2%) 
Education; n (%)        
0.061 
Chi square test 
(n = 89)  None/GCSE 7 (28.0%) 
35 
(50.7%) 
5 
(45.5%) 
5 (41.7%) 
12 
(57.1%) 
13 (52.0%) 
42 
(44.7%) 
 A level 3 (12.0%) 
16 
(23.2%) 
4(36.4%) 2 (16.7%) 5 (23.8%) 5 (20.0%) 
19 
(20.2%) 
 Degree/higher 
degree 
11 
(44.0%) 
17 
(24.6%) 
2 
(18.2%) 
5 (41.7%) 3 (14.3%) 7 (28.0%) 
28 
(29.8%) 
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 [Missing] 4 (16.0%) 1 (1.4%) - - 1 (4.8%) - 5 (5.3%) 
Marital status; n (%)        
< 
0.001 
Chi square test 
  Married/cohabiting 20 
(80.0%) 
22 
(31.9%)  
1 (9.1%) 6 (50.0%) 5 (23.8%) 10 (40.0%) 
42 
(44.7%) 
 Single/separated/ 
widowed 5 (20.0%) 
47 
(68.1%) 
10 
(90.9%) 
6 (50.0%) 
16 
(76.2%) 
15 (60.0%) 
52 
(55.3%) 
 
Table 2: Unadjusted mean scores (with standard deviation) and count (%) for each measurement scale and subscales 
Measurement scale Controls 
(n = 25) 
Cases (n = 69) 
All 
(n = 94) 
Case versus control 
(General linear 
models, F test) 
Bipolar 
(n = 11) 
Borderline 
(n = 12) 
Psychosis 
(n = 21) 
Depression 
(n = 25) 
ACS (scale 1-7) 3.36 (0.56) 4.39 (0.66) 5.14 (0.58) 4.23 (0.86) 4.52 (0.86) 4.21 (0.92) p<0.001 
 ACS: Anger 3.06 (0.60) 4.31 (0.83) 5.21 (0.96) 4.07 (0.89) 4.08 (1.15) 3.97 (1.11)  
 ACS: Positive-affect 3.48 (0.63) 4.17 (0.73) 4.12 (1.02) 4.05 (0.89) 3.87 (1.03) 3.88 (0.89)  
 ACS: Depressed 3.36 (0.75) 4.96 (0.88) 5.92 (0.72) 4.40 (1.01) 5.38 (1.04) 4.64 (1.27)  
 ACS: Anxiety 3.42 (0.57) 4.31 (0.84) 5.63 (0.60) 4.42 (1.23) 4.93 (0.95) 4.43 (1.13)  
ALS-18 (scale 0-3) 0.64 (0.58) 1.47 (0.62) 1.66 (0.49) 1.53 (0.67) 1.50 (0.62) 1.29 (0.71) p<0.0011 
 ALS-18: Anxiety/Depression 0.55 (0.65) 1.49 (0.69) 2.23 (0.79) 1.60 (1.01) 1.88 (0.87) 1.46 (1.00)  
 ALS-18: Depression/Elation 0.86 (0.70) 1.66 (0.57) 1.45 (0.58) 1.65 (0.73) 1.52 (0.53) 1.38 (0.70)  
 ALS-18: Anger 0.38 (0.48) 1.16 (0.95) 1.42 (0.96) 1.27 (0.88) 1.08 (1.03) 0.99 (0.92)  
AIM (scale 1-6) 3.50 (0.48) 3.45 (0.37) 3.37 (0.44) 3.42 (0.56) 3.37 (0.39) 3.42 (0.45) p=0.867 
Number of mood fluctuations 
reported in the last week 
      P=0.310 
0 
1-3 
4-7 
>7 
13 (52%) 
10 (40%) 
2 (8%) 
0 (0%) 
2 (18.2%) 
5 (45.5%) 
3 (27.3%) 
1 (9.1%) 
0 (0%) 
3 (25%) 
7 (58.3%) 
2 (16.7%) 
5(23.8%) 
4 (19%) 
7 (33.3%) 
5 (23.8%) 
2 (8%) 
8 (32%) 
7 (28%) 
8 (32%) 
22 (23.4%) 
30 (31.9%) 
26 (27.7%) 
16 (17.0%) 
 
WHODAS2 (scale 0-4) 0.54 (0.11) 1.43 (0.61) 1.83 (0.69) 1.75 (1.00) 1.89 (0.91) 1.44 (0.96) p<0.001 
                                                 
1
 Adjusted for age. 
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Table 3: Correlation coefficients between each pair of measurement scales 
 
Full -sample (N=94) 
  AIM ALS-18 ACS Mood fluctuation (last week) 
AIM  1 0.210 0.188 0.12 
ALS-18   1 0.776 0.61 
ACS    1 0.53 
Mood fluctuation 
(last week) 
 
   
1 
      
Cases only (N=69) 
  AIM ALS-18 ACS Mood fluctuation (last week) 
AIM  1 0.322 0.265 0.157 
ALS-18   1 0.666 0.45 
ACS    1 0.29 
Mood fluctuation 
(last week) 
 
   
1 
 
                                                                                                                                                                                                                                          
 
 
 
 
